Key result
Pir4-VP8* inoculation in mice confers ~60% protection against rotavirus infection in offspring.
Yeast-expressed Pir4-VP8* fusion protein is highly immunogenic in mice and provides passive protection to offspring against rotavirus infection.
May inform maternal rotavirus vaccine strategies; leaves open human translation and trials.
The VP8* fragment from the rotavirus spike protein was expressed as a fusion protein with two different cell wall proteins of Saccharomyces cerevisiae, Icwp (Ssr1p) and Pir4, to achieve cell wall targeting or secretion to the growth medium of the fusion proteins. Two different host strains were used for the expression of the fusion proteins, a standard S. cerevisiae strain and a mnn9 glycosylation deficient strain, the later to reduce hyper-glycosylation. The Icwp-VP8* fusion could only be detected in the growth medium, indicating that the presence of the VP8* moiety interferes with the anchorage of Icwp to the cell wall. In the case of the Pir4-VP8* fusion proteins, we achieved cell wall targeting or secretion depending on how the gene fusion had been performed. In all cases, the fusion proteins expressed in the mnn9 strain showed a reduced level of glycosylation. Mice were inoculated intraperitoneally either with Pir4-VP8* or Icwp-VP8* fusion proteins purified from the growth medium of mnn9 strains expressing them or with whole cells of an mnn9 strain expressing a Pir4-VP8 fusion protein on its cell walls. Hundred percent of mice inoculated with the Pir4-VP8* fusion protein and 25% of those inoculated with the Icwp-VP8* fusion protein showed high titers of anti-VP8* antibodies. No specific immune response was detected in those mice inoculated with whole cells. Finally, susceptibility to rotavirus infection of the offspring of immunized dams was determined and protection was found in a percentage of approximately 60% with respect to the control group.
No takes yet. Share an insight, caveat, or question.
Andrés et al. (2005) studied Rotavirus infection. Pir4-VP8* or Icwp-VP8* fusion proteins vs. Control group was evaluated on Protection against rotavirus infection in offspring of immunized dams. Inoculation of mice with the Pir4-VP8* fusion protein elicited high antibody titers in 100% of mice and provided approximately 60% protection against rotavirus infection in their offspring.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: